These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30462974)

  • 1. [Analysis of risk factors of ventricular arrhythmia in patients with Brugada syndrome].
    Shen TT; Geng J; Yuan BB; Chen C; Zhou XJ; Shan QJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):862-867. PubMed ID: 30462974
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome.
    Maury P; Sacher F; Gourraud JB; Pasquié JL; Raczka F; Bongard V; Duparc A; Mondoly P; Sadron M; Chatel S; Derval N; Denis A; Cardin C; Davy JM; Hocini M; Jaïs P; Jesel L; Carrié D; Galinier M; Haïssaguerre M; Probst V; Rollin A
    Heart Rhythm; 2015 Dec; 12(12):2469-76. PubMed ID: 26209263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST-segment elevation and the Tpeak-Tend/QT ratio predict the occurrence of malignant arrhythmia events in patients with vasospastic angina.
    Wang X; Zhang L; Gao C; Wu S; Zhu J
    J Electrocardiol; 2019; 53():52-56. PubMed ID: 30616002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tpeak-Tend interval and Tpeak-Tend/QT ratio in patients with Brugada syndrome.
    Zumhagen S; Zeidler EM; Stallmeyer B; Ernsting M; Eckardt L; Schulze-Bahr E
    Europace; 2016 Dec; 18(12):1866-1872. PubMed ID: 26941339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged QRS duration in lead V2 and risk of life-threatening ventricular Arrhythmia in patients with Brugada syndrome.
    Ohkubo K; Watanabe I; Okumura Y; Ashino S; Kofune M; Nagashima K; Kofune T; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2011; 52(2):98-102. PubMed ID: 21483168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
    Andorin A; Gourraud JB; Mansourati J; Fouchard S; le Marec H; Maury P; Mabo P; Hermida JS; Deharo JC; Delasalle B; Esnault S; Sadoul N; Davy JM; Leenhardt A; Klug D; Defaye P; Babuty D; Sacher F; Probst V
    Heart Rhythm; 2017 Aug; 14(8):1147-1154. PubMed ID: 28411139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Exercise Testing in Risk Stratification of Asymptomatic Patients With Type 1 Brugada Pattern.
    Subramanian M; Prabhu MA; Harikrishnan MS; Shekhar SS; Pai PG; Natarajan K
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):677-683. PubMed ID: 28316113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome.
    Castro Hevia J; Antzelevitch C; Tornés Bárzaga F; Dorantes Sánchez M; Dorticós Balea F; Zayas Molina R; Quiñones Pérez MA; Fayad Rodríguez Y
    J Am Coll Cardiol; 2006 May; 47(9):1828-34. PubMed ID: 16682308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of ventricular fibrillation in Brugada syndrome using noninvasive scoring methods.
    Kawazoe H; Nakano Y; Ochi H; Takagi M; Hayashi Y; Uchimura Y; Tokuyama T; Watanabe Y; Matsumura H; Tomomori S; Sairaku A; Suenari K; Awazu A; Miwa Y; Soejima K; Chayama K; Kihara Y
    Heart Rhythm; 2016 Oct; 13(10):1947-54. PubMed ID: 27424075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
    Ueoka A; Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Miyamoto M; Nakagawa K; Nishii N; Ito H
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.
    Brugada J; Brugada R; Brugada P
    Circulation; 2003 Dec; 108(25):3092-6. PubMed ID: 14623800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of ventricular arrhythmias in patients with a spontaneous Brugada type 1 pattern: the key is in the electrocardiogram.
    Delinière A; Baranchuk A; Giai J; Bessiere F; Maucort-Boulch D; Defaye P; Marijon E; Le Vavasseur O; Dobreanu D; Scridon A; Da Costa A; Delacrétaz E; Kouakam C; Eschalier R; Extramiana F; Leenhardt A; Burri H; Winum PF; Taieb J; Bouet J; Fauvernier M; Rosianu H; Carabelli A; Duband B; Chevalier P
    Europace; 2019 Sep; 21(9):1400-1409. PubMed ID: 31177270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-domain T-wave alternans is strongly associated with a history of ventricular fibrillation in patients with Brugada syndrome.
    Uchimura-Makita Y; Nakano Y; Tokuyama T; Fujiwara M; Watanabe Y; Sairaku A; Kawazoe H; Matsumura H; Oda N; Ikanaga H; Motoda C; Kajihara K; Oda N; Verrier RL; Kihara Y
    J Cardiovasc Electrophysiol; 2014 Sep; 25(9):1021-1027. PubMed ID: 24761970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T
    Tse G; Gong M; Li CKH; Leung KSK; Georgopoulos S; Bazoukis G; Letsas KP; Sawant AC; Mugnai G; Wong MCS; Yan GX; Brugada P; Chierchia GB; de Asmundis C; Baranchuk A; Liu T;
    J Arrhythm; 2018 Dec; 34(6):587-597. PubMed ID: 30555602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3.
    Kamakura S; Ohe T; Nakazawa K; Aizawa Y; Shimizu A; Horie M; Ogawa S; Okumura K; Tsuchihashi K; Sugi K; Makita N; Hagiwara N; Inoue H; Atarashi H; Aihara N; Shimizu W; Kurita T; Suyama K; Noda T; Satomi K; Okamura H; Tomoike H;
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):495-503. PubMed ID: 19843917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline fragmented QRS increases the risk of major arrhythmic events in Brugada syndrome: Systematic review and meta-analysis.
    Rattanawong P; Riangwiwat T; Prasitlumkum N; Limpruttidham N; Kanjanahattakij N; Chongsathidkiet P; Vutthikraivit W; Chung EH
    Ann Noninvasive Electrocardiol; 2018 Mar; 23(2):e12507. PubMed ID: 29030919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.